Founding investors GE Ventures and Mayo Clinic Ventures have taken part in a $13.8m round for Vineti, which aims to increase access to gene and cellular therapies.
US-based cellular therapy engagement software developer Vineti has completed a $13.8m series A round that included subsidiaries of industrial product maker General Electric (GE) and medical researcher Mayo Clinic.
GE Ventures and Mayo Clinic Ventures were joined by venture capital firm DFJ and LifeForce Capital, both of which participated in the round as new investors.
GE and Mayo Clinic founded Vineti, which is developing a cloud-based platform that integrates elements of logistics, manufacturing and clinical data to expand access for…
